TherapeuticsMD, Inc. TXMD
Set alert
1.81 USD +0.01 +0.56%
At close · Nov 2
1.81 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.77 Day range 1.82
1.11 52-week range 2.95
- YTD
- +11.04%
- 1 year
- +52.10%
- Open
- 1.80
- Prev close
- 1.80
- Mkt cap
- 20.95M
- Vol
- 8.52K
- Avg vol
- 23.65K
- EPS
- -0.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.77
- High
- 1.82
- Forward P/E
- 3.13
- Beta
- 0.00
- Short ratio
- 0.95
- Inst. own
- 44.53%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.42
- 200-d avg
- 1.79
- 1y target
- 0.00
3M chart
Signals (17)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
Financial health
Altman Z-Score
-34.36 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -33.1×
FY 2016 5y median -4.1× FY 2025
P/S 6.2×
FY 2016 5y median 6.2× FY 2025
P/B 0.7×
FY 2016 5y median 0.7× FY 2025
P/FCF 7.8×
FY 2016 5y median 0.0× FY 2025
EV/EBITDA -5.8×
FY 2016 5y median -3.5× FY 2025
EV/Sales 5.8×
FY 2016 5y median 6.8× FY 2025
FCF Yield 12.9%
FY 2016 5y median 0.0% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -139.4%
FY 2016 5y median -275.1% FY 2025
Net Margin -18.8%
FY 2016 5y median -123.9% FY 2025
ROE -2.1%
FY 2016 5y median -2.1% FY 2025
ROIC -12.5%
FY 2016 5y median -13.5% FY 2025
ROA -1.5%
FY 2016 5y median -5.6% FY 2025
Growth (YoY)
Revenue 71.6%
FY 2016 FY 2025
Operating Income 13.0%
FY 2016 FY 2025
EPS (diluted) 74.1%
FY 2016 FY 2025
Free Cash Flow 231.1%
FY 2016 FY 2025
Financial Health
Current Ratio 3.0×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 3.0×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median -0.5× FY 2025
Interest Coverage -527×
FY 2016 5y median -2.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
